Articles

• Open Access

  Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder

  Velina S. Chavarro, Maureen A. Mealy, Alexandra Simpson, Anna Lacheta, Florence Pache, Klemens Ruprecht, Stefan M. Gold, Friedemann Paul, Alexander Ulrich Brandt, Michael Levy

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Microarray screening of Guillain-Barré syndrome sera for antibodies to glycolipid complexes

  Susan K. Halstead, Gabriela Kalna, Mohammad B. Islam, Israt Jahan, Quazi D. Mohammad, Bart C. Jacobs, Hubert P. Endtz, Zhahirul Islam, Hugh J. Willison

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis

  Catharina C. Gross, Diana Ahmetspahic, Tobias Ruck, Andreas Schulte-Mecklenbeck, Kathrin Schwarte, Silke Jörgens, Stefanie Scheu, Susanne Windhagen, Bettina Graefe, Nico Melzer, Luisa Klotz, Volker Arolt, Heinz Wiendl, Sven G. Meuth, Judith Alferink

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease

  Tua Vinther-Jensen, Lars Börnsen, Esben Budtz-Jørgensen, Cecilie Ammitzbøll, Ida U. Larsen, Lena E. Hjermind, Finn Sellebjerg, Jørgen E. Nielsen

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy

  Masato Kadoya, Ayumi Hida, Meiko Hashimoto Maeda, Kenichiro Taira, Chiseko Ikenaga, Naohiro Uchio, Akatsuki Kubota, Kenichi Kaida, Yusuke Miwa, Kazuhiro Kurasawa, Hiroyuki Shimada, Masahiro Sonoo, Atsuro Chiba, Yasushi Shiio, Yoshikazu Uesaka, Yasuhisa Sakurai, Toru Izumi, Manami Inoue, Shin Kwak, Shoji Tsuji, Jun Shimizu

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Induction of gut regulatory CD39⁺ T cells by teriflunomide protects against EAE

  Javier Ochoa-Repáraz, Sara L. Colpitts, Christopher Kircher, Eli J. Kasper, Kiel M. Telesford, Sakhina Begum-Haque, Anudeep Pant, Lloyd H. Kasper

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Natalizumab treatment leads to an increase in circulating CXCR3-expressing B cells

  Maija Saraste, Tarja-Leena Penttilä, Laura Airas

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Blood–brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV

  Birgitta Anesten, Aylin Yilmaz, Lars Hagberg, Henrik Zetterberg, Staffan Nilsson, Bruce J. Brew, Dietmar Fuchs, Richard W. Price, Magnus Gisslén

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Risk of relapse after natalizumab withdrawalResults from the French TYSEDMUS cohort

  Caroline Papeix, Sandra Vukusic, Romain Casey, Nadine Debard, Bruno Stankoff, Serge Mrejen, Zoe Uhry, Eric Van Ganse, Anne Castot, Michel Clanet, Catherine Lubetzki, Christian Confavreux, For the TYSEDMUS and OFSEP Group

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Increased prevalence of autoimmune disease within C9 and FTD/MND cohortsCompleting the picture

  Zachary A. Miller, Virginia E. Sturm, Gamze Balci Camsari, Anna Karydas, Jennifer S. Yokoyama, Lea T. Grinberg, Adam L. Boxer, Howard J. Rosen, Katherine P. Rankin, Maria Luisa Gorno-Tempini, Giovanni Coppola, Daniel H. Geschwind, Rosa Rademakers, William W. Seeley, Neill R. Graff-Radford, Bruce L. Miller

  • Abstract
  • Full Text
  • Full Text (PDF)